Thank you for taking the preassessment Thank you for taking the preassessment. (Note: the questions were developed by an independent consulting group with expertise in assessing the effectiveness of medical education.) To assess learning, these questions will be repeated at the end of the activity.

Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

“Pleiotropic” Non-BP-Lowering Effects of Renal Denervation

ALSTER BP Registry: Efficacy and Safety of Redo Renal Denervation in Nonresponders

Renal Artery Stenosis After Renal Denervation

Case Reports of Renal Artery Stenosis After Renal Denervation

Symplicity HTN-1: eGFR Stable So Far

Urinary Albumin Excretion

EnligHTN First in Man: Renal Function

Surrogates of Vascular Stiffness Reduced With Renal Denervation

Small Reductions in BP Lower Stroke/IHD Mortality

EnligHTNment Trial (Design Not Finalized)

European Society of Cardiology Consensus: Eligibility

Multidisciplinary Team Considerations

Avoid RDN in Stented Renal Arteries

Symplicity Spyral First in Man

Symplicty Global Registry (149 Sites)

Abbreviations

References

References (cont)

References (cont)

References (cont)

References (cont)